Navigation Links
IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
Date:2/5/2008

apital Market in accordance with Marketplace Rule 4310(c), other than compliance with the minimum bid price requirement. If the application to the NASDAQ Capital Market is approved, then the Company will have an additional 180-day compliance period in order to regain compliance with the minimum bid price requirement while listed on the NASDAQ Capital Market.

About IDM Pharma

IDM Pharma is focused on the development of innovative cancer products that either destroy cancer cells by activating the immune system or prevent tumor recurrence by triggering a specific adaptive immune response. IDM Pharma is dedicated to maximizing the full therapeutic and commercial potential of each of its innovative products to address the needs of patients and the physicians who treat these patients.

For more information about the company and its products, visit http://www.idm-pharma.com.

Forward-Looking Statements

This press release includes forward-looking statements that reflect management's current views of future events including statements regarding the Company's ability to comply with the minimum bid price requirements under the NASDAQ Marketplace Rules. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, whether the Company will be able to maintain a closing bid price of $1.00 per share or higher for a minimum of 10 consecutive trading days and risks relating to the Company's ability to comply with other NASDAQ requirements. Other risks affecting the Company and its drug development programs are more fully discussed in the Company's Quarterly Report on Form 10-Q filed with the SEC for the quarter ended September 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.


'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
2. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
3. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
4. ARMSRx Tackles the New Rx Addiction -- Pharmacy Benefit Audits
5. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
6. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
7. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
10. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
11. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... NV (PRWEB) July 31, 2014 Weblify has ... after 4 years of development and testing. The result ... monetized websites in as little as 5 minutes without knowing ... full Weblify review , Shane Michaels, an SEO expert, agrees ... quickly. “I’ve seen a lot of web site builders ...
(Date:7/31/2014)... Jeremiah’s Tavern joins ... to create a unique atmosphere and highlight their ... reclaimed barn siding on the exterior ... softwoods flowing throughout the interior as flooring. In ... company New Energy Works Timberframers add ...
(Date:7/31/2014)... Ticket Down is a dependable source ... at the Sun Life Stadium in Miami on Monday, August ... underway. Residents and diehard soccer fans from the Miami, Florida ... International Champions Cup final in person at Sun Life Stadium. ... have been split into two groups where they will then ...
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 A program ... is coming to the University of Colorado Anschutz ... destination weight loss boot camp and transformation program. ... between AHWC and Eyeworks USA, is an evidenced-based program ... for ABC by Eyeworks USA. This season, the show ...
Breaking Medicine News(10 mins):Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:Popular Tavern Restaurant Features Pioneer Millworks’ Reclaimed Wood in New Locations 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3
... at work are more likely than long hours, night ... interfere with their sleep. , That,s the conclusion of ... the annual meeting of the Population Association of America. ... approximately 2,300 U.S. adults that monitored the same workers ...
... Antibiotic-Resistant Pathogens Earn Avelox Gold Standard Status Through ... According to a New Report from Decision Resources, ... one of the,world,s leading research and advisory firms ... therapy,s overall clinical efficacy,(defined as cure or improvement ...
... Bionovo Inc.,(Nasdaq: BNVI ) announced today the appointment ... Directors. Dr. Baxter has extensive experience in,academic research as ... in advancing endocrine drugs., "We are very excited ... our,clinical trial programs," said Isaac Cohen, O.M.D., Bionovo,s Chairman ...
... April 17 Eisai Corporation of,North America today ... President of U.S. Corporate Communications. In this newly ... and coordinating,all of Eisai,s corporate communications strategies and ... to Eisai more than 22 years of global ...
... BERKELEY, Calif., April 17 Losing your home to,foreclosure ... loved one. And with so,many Americans facing this dreaded ... in default, according to USA TODAY (Nov. 11,2007) -- ... as,the financial and practical ones., In her seminal ...
... a life,sciences company based in Shanghai, China and ... made several executive management appointments to,build out its ... has joined ProGenTech as its Vice President for ... the global R&D programs,and have accountability for the ...
Cached Medicine News:Health News:U-M study: Work hassles hamper sleep 2Health News:Bayer/Schering-Plough/Shionogi's Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia 2Health News:John D. Baxter, M.D. Joins Bionovo's Board of Directors 2Health News:John D. Baxter, M.D. Joins Bionovo's Board of Directors 3Health News:Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications 2Health News:Nolo.com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 2Health News:Nolo.com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 3Health News:ProGenTech Limited Appoints Executive Management Team 2
(Date:7/31/2014)... VALLEJO, Calif. , July 31, 2014 ... announce it has been selected as the recipient of ... Foundation, which will allow the University to increase research ... is about creating state-of-the-art technology for the study of ... that enhance the diverse needs and interests of our ...
(Date:7/31/2014)... 31, 2014 For its innovative modular Biomedical ... , Art,s-Way Scientific has earned a Modular Building Institute ... in over 30 categories, MBI,s contest is the commercial ... include building manufacturers, dealers, and product and service providers. ... the capability of our team," said Dan Palmer ...
(Date:7/31/2014)... , July 31, 2014 AFFiRiS AG ... York results of AFF008, a Phase I clinical ... the first therapy against the protein alpha-synuclein, a promising Parkinson,s ... J. Fox Foundation for Parkinson,s Research (MJFF) supported the study ... press conference on the impact a disease-modifying therapy would have ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
... a commercial stage private oncology company, announced today ... executives to its Global Commercialization Team.  The Global ... new tumor treating fields (TTF) cancer therapy to ... has joined Novocure as chief commercial officer responsible ...
... (OTCBB: POSC), a leading molecular imaging company specializing in ... today that on December 12, 2011, the Company,s Positron ... approval for sale in Canada. The ... the Attrius systems manufacturer, Neusoft Positron Medical Systems. NPMS ...
Cached Medicine Technology:Novocure Adds Three Senior Oncology Executives to its Global Management Team 2Novocure Adds Three Senior Oncology Executives to its Global Management Team 3Novocure Adds Three Senior Oncology Executives to its Global Management Team 4Positron's Attrius Receives Health Canada Approval 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: